Brickell Biotech Inc reports results for the quarter ended in June - Earnings Summary

Fresh Tracks Therapeutics

12/08/2021 21:58

* Brickell Biotech Inc  BBI.OQ  reported a quarterly adjusted
loss of 16 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 12 cents per share.
* Revenue was $151.00 thousand​;  analysts expected $50.00
thousand. 
* Brickell Biotech Inc's reported EPS for the quarter was a loss
of 16 cents​.
* The mean earnings estimate of analysts had fallen by
about 13.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Brickell Biotech Inc shares had fallen by 30.6% this
quarter and lost 15.5% so far this year.
* The company reported a quarterly loss of $11.15 million.
* Wall Street's median 12-month price target for Brickell
Biotech Inc is $5.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 08:58 p.m.  ​All
figures in US dollars unless otherwise stated